Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Clinical Medicine
  4. Vol 6, Issue 5, 2025

Current Status and Advances in the Diagnosis and Management of Cystitis Glandularis

Download as PDF

DOI: 10.23977/medsc.2025.060509 | Downloads: 6 | Views: 103

Author(s)

Yaxi Wang 1,2, Guangdong Hou 3, Fuli Wang 2

Affiliation(s)

1 College of Clinical Medicine, Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi, China
2 Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
3 Department of Urology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China

Corresponding Author

Fuli Wang

ABSTRACT

Cystitis Glandularis is a proliferative and metaplastic lesion of the bladder mucosa. Studies have found that Cystitis Glandularis is associated withthe occurrence and development of bladder cancer. In recent years, its incidence has been increasing, it is prone to recurrence after treatment, and theprognosis is poor. The etiology of Cystitis Glandularis is complex, and its clinical manifestations lack specificity. However, clinical diagnostic and therapeutic strategies have advanced rapidly. This article aims to systematically review the new advances in its diagnosis and treatment, providing a reference for clinical practice.

KEYWORDS

Cystitis Glandularis; Diagnosis, Precancerous Lesion, Current Management, Recent Advances

CITE THIS PAPER

Yaxi Wang, Guangdong Hou, Fuli Wang, Current Status and Advances in the Diagnosis and Management of Cystitis Glandularis. MEDS Clinical Medicine (2025) Vol. 6: 62-70. DOI: http://dx.doi.org/10.23977/medsc.2025.060509.

REFERENCES

[1] Yue X.L, Liu Z.M, Yu Y. (2018)Current understanding and treatment status of glandular cystitis. World Latest Medical Information Abstracts, 18(19): 252. 
[2] Jeon J, Ha J.S, Shin S.J.(2023) MP22-03 clinical significance of cystitis glandularis in patients without a previous history of urinary malignancy. The Journal of Urology, 209(Supplement 4): e296.
[3] Chu C.L, Zhao C.H, Zhang Z.W, Wang M.W, Zhang Z.H, Yang A.Q, Ma B.B, Lu C.F, Wu M, Gu M.Z, Cui R.J, Xin Z.X, Huang T, Zhou W.L.(2017) Identification and Validation of Gene Expression Patterns in Cystitis Glandularis Patients and Controls. SLAS Discov,22(6):743-750. 
[4] Chen Z.Q, Ye Z.Q, Li J.G, Zhou S.W, Zhuang Q.Y, Yang W.M, Liu J.H, Zhang X, Du G.H. (2002). Clinical and pathological features of bladder mucosal proliferative lesions: A report of 42 cases. Chinese Journal of Urology, (02), 35-37.
[5] Shao Y.S, Huang X. (2011). Etiological analysis and treatment experience of cystitis glandularis. Sichuan Medical Journal, 32(7), 1106-1108
[6] Ge B, Guo C, Liang Y, Liu M, Wu K.(2019) Network analysis and human and animal studies disclose the anticystitis glandularis effects of vitamin C. Biofactors. 45(6):912-919.
[7] Chu C.L, Zhao C.H, Zhang Z.W, Wang M.W, Zhang Z.H, Yang A.Q, Ma B.B, Lu C.F, Wu M, Gu M.Z, Cui R.J, Xin Z.X, Huang T, Zhou W.L. (2017)Identification and Validation of Gene Expression Patterns in Cystitis Glandularis Patients and Controls. SLAS Discov,22(6):743-750.
[8] Zhang X.B, Zhang Q.Q, Liu C, Wang K. (2019). Progress in diagnosis and treatment of cystitis glandularis. Chinese Journal of Endourology (Electronic Edition), 13(4), 271-274.
[9] Wang N, Chen Z.Q. (2016). New insights into non-bacterial cystitis. Chinese Journal of Clinical Urology, 31(7), 663-669.
[10] Pantanowitz L, Otis C.N. Cystitis glandularis. Diagn Cytopathol (2008) 36(3). 
[11] Wu J W, Chen J, Mo Z N, Lü Z.L. (2001). Association between human papillomavirus and cystitis glandularis. Chinese Journal of Urology, 22(3), 175-176.
[12] Zhang B. (2021). Interpretation of the Chinese expert consensus on clinical diagnosis and treatment of cystitis glandularis. Journal of Urology (Electronic Edition), 13(4), 28-31.
[13] Yang Y. (2013). How to correctly understand cystitis glandularis. Chinese Journal of Urology, 34(3), 165-166.
[14] Guo A, Liu A, Teng X. (2016) The pathology of urinary bladder lesions with an inverted growth patter. Chinese Journal of Cancer Research, 28(1): 107.
[15] Zhang T, Yin S.F, Feng W.B, Ke C.X. (2023)Florid cystitis glandularis (intestinal type) with mucus extravasation: Two case reports and literature review. Front Surg, 24
[16] Li Z, Ge G, Feng R, Wu D, Shen B, Wang X, Cui Y, Li J, Ju X. (2014)Cyclooxygenase-2 and B-cell lymphoma-2 expression in cystitis glandularis and primary vesicle adenocarcinoma. BMC Urol, 14:2. 
[17] CHENG L, WANG X.L, XU K, LI J.S, SONG Q. (2023). Value of Multiparameter MRI in Differentiating Cystitis Glandularis from Bladder Cancer and Diagnosing Pathological Staging of Bladder Cancer. Progress in Modern Biomedicine, 23(24).
[18] Zhou T.L, Chen H.X, Wang Y.Z, Wen S.J, Dao P.H, Wang Y.H, Chen M.F. (2023)Single-cell RNA sequencing reveals the immune microenvironment and signaling networks in cystitis glandularis. Front Immunol, 14:1083598. 
[19] Chinese Urological Association, Expert Consensus Writing Group on Cystitis Glandularis. (2020). Chinese expert consensus on clinical diagnosis and treatment of cystitis glandularis. Chinese Journal of Urology, 41(8), 566-568.
[20] Zhang H , Ma D.J, Zou X.X, Zhang Q, Qin D.J. (2018). MSCT manifestations and differential diagnosis of cystitis glandularis. Journal of Medical Imaging, 28(8), 1342-1344+1358.
[21] Li C, Hu J, Liu P, Li Q, Chen J, Cui Y, Zhou X, Xue B, Zhang X, Gao X, Zu X. (2020)A comprehensive evaluation of differentially expressed mRNAs and lncRNAs in cystitis glandularis with gene ontology, KEGG pathway, and ceRNA network analysis. Transl Androl Urol, 9(2):232-242. 
[22] Chu C.L, Zhao C.H, Zhang Z.W, Wang M.W, Zhang Z.H, Yang A.Q, Ma B.B, Lu C.F, Wu M, Gu M.Z, Cui R J, Xin Z.X, Huang T, Zhou W.L. (2017) Identification and Validation of Gene Expression Patterns in Cystitis Glandularis Patients and Controls. SLAS Discov, 22(6):743-750. 
[23] Jeon J, Ha J.S, Shin S.J. (2023)MP22-03 CLINICAL SIGNIFICANCE OF CYSTITIS GLANDULARIS IN PATIENTS WITHOUT A PREVIOUS HISTORY OF URINARY MALIGNANCY. The Journal of Urology, 2023.
[24] Ding Y.C, Shi H.B, Yang X.B, Chen F.B.(2011). Diagnosis and treatment of cystitis glandularis complicated with overactive bladder. Journal of Modern Urology, 16(1), 58-60.
[25] Mo L.C, Piao S.Z, Zheng H.H, Hong T, Feng Q, Ke M. (2021)Pelvic lipomatosis with cystitis glandularis managed with cyclooxygenase-2 inhibitor: A case report. World J Clin Cases, 9(17):4373-4380. 
[26] Tong X.L, Gong D.X, Liu Y.L, He Z.Y, Zhao W, Sun Z.X, Kong C.Z. (2003). Exploration of treatment methods for cystitis glandularis. Chinese Journal of Surgery, 48-50.
[27] Zhou K.(2015) Analysis of the application effect of transurethral resection in urology. Chinese and Foreign Medical Research, 13(8): 51-53.
[28] Hu W. (2019)Value analysis of transurethral resection in urological treatment. World Latest Medical Information Abstracts, 19(70): 130-131.
[29] Ma J.X, Zhang T, Xie D.D. (2018)Management techniques and safety analysis of lost ureteral orifice during transurethral resection of bladder tumors. International Journal of Urology and Nephrology, 38(1): 102-105.
[30] Chen T, Li H, Wang L, Chen C.B, Yang Y.(2020). Diagnosis and treatment analysis of 2 cases of cystitis glandularis with abnormal ureteral orifice. Journal of Modern Urology, 25(5), 460-461.
[31] Ni Y, Zhao S, Yin X, Wang H, Guang Q, Hu G, Yang Y, Jiao S, Shi B. (2017)Intravesicular administration of sodium hyaluronate ameliorates the inflammation and cell proliferation of cystitis cystica et glandularis involving interleukin-6/JAK2/Stat3 signaling pathway. Sci Rep, 7(1):15892. 
[32] Wu S.Q, Tang X.Y, Wen D.J, Tang M, Xu R, Zhu X, Zhao X.K. (2015). Efficacy observation of transurethral resection combined with mitomycin perfusion versus transurethral resection alone in the treatment of cystitis glandularis. Chinese Journal of Clinical Urology, 30(6), 549-551.
[33] Su X, Gao X.L, Ma SJ, Hu W, Guo F, Zhang R, Qin W.J, Wang F.L. (2022). Risk factors for recurrence in patients with cystitis glandularis after transurethral resection of lesions. Journal of Modern Urology, 27(8), 635-640.
[34] Takizawa N, Matsuzaki T, Yamamoto T, Mishima T, Miyasaka C, Tanaka S, Kinoshita H, Uemura Y, Yamada H, Matsuda T. (2016)Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase-2 inhibitor. Int J Urol, 23(8):706-708. 
[35] Hong T, Tao Y.R, Piao S.Z, Ke M.(2022)Expression and clinical significance of COX-2, HRH1 and PTGS2 in cystitis glandularis. China Journal of Modern Medicine, 60(18): 4-6+10.
[36] Takahashi S. (2016)Editorial Comment to Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase-2 inhibitor. Int J Uro,23(8):709.
[37] Yuksel OH, Urkmez A, Erdogru T, Verit A. (2015)The role of steroid treatment in intractable cystitis glandularis: A case report and literature review. Can Urol Assoc J, 9(5-6):E306-309. 
[38] Jhang J.F. (2019)Using botulinum toxin a for treatment of interstitial cystitis/bladder pain syndrome—Possible pathomechanisms and practical issues[J]. Toxins,11(11): 641.
[39] Feng Z, Shi H, Liang B, Ge T, Cai M, Liu F, Huang K, Wen J, Chen Q, Ge B. (2021)Bioinformatics and experimental findings reveal the therapeutic actions and targets of pachymic acid against cystitis glandularis. Biofactors., 47(4):665-673. 
[40] Ge B, Guo C, Liang Y, Liu M, Wu K. (2019)Network analysis, and human and animal studies disclose the anticystitis glandularis effects of vitamin C. Biofactors, 48(2):254. 
[41] Bai S.J, Chen X.B, Zeng T.B. (2023)Treatment progress of cystitis glandularis. Asian J Surg, 46(6):2444.
[42] Kitamura N, Yamamoto Y, Yamamoto N, Murase T. (2023)Rosmarinic acid ameliorates HCl-induced cystitis in rats. PLoS One, 18(7):e0288813.
[43] Chen Q, Mo J, Li Y, Gao L, Wu K. (2024)Anti-Inflammatory Action and Molecular Mechanism of Fucoidan Against Cystitis Glandularis. Food Sci Nutr, 12(12):10255-10261.
[44] Wang B, Reed-Maldonado A.B, Ly K, Lin G, Lue T.F. (2022) Potential Applications of Low-Intensity Extracorporeal Shock Wave Therapy in Urological Diseases via Activation of Tissue Resident Stem Cells. Urol. Sci, 33:3–8.
[45] Pan T.J, Gong W, Liu B, Liu Y.(2025). Current status and new technological prospects in the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Chinese Journal of Clinical Urology, 40(8), 677-682.
[46] Burchette J E, Covert K, Tu P, White B P, Chastain D B, Cluck D B. (2025) Pivmecillinam for Uncomplicated Acute Cystitis: A Contemporary Review. Ann Pharmacother, 59(8):743-757.
[47] Hu H, Tang Y, Zhou B, Chen S, Su J, Zhong W, Wei Y, Huang Y, Ge B. (2025) Anti-cystitis glandularis action exerted by glycyrrhetinic acid: bioinformatics analysis and molecular validation. Molecular Diversity,1-10.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 9890
Visits: 650861

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.